Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07322588

Reentry Incentives and Support for Engagement With Contingency Management

People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return to the community.

In this study, people who are taking MOUD in jail can choose to participate. While still incarcerated, they complete one visit where they may receive a small incentive, such as commissary credit or snacks, for enrolling in the CM program. After they leave jail, participants can earn gift cards when they attend their MOUD appointments and counseling sessions.

Participants may take part in the study for up to three months after release. During this time, they can earn up to $600 in incentives based on their treatment engagement. Researchers will also ask participants to complete a baseline survey and a survey at 3 months. We will also review medical records to confirm whether they continued their MOUD.

The researchers want to learn whether this adapted contingency management program is feasible, acceptable to participants, and helpful for supporting treatment engagement after release from jail. The findings will help determine whether this approach should be tested in a larger study to reduce overdose risk and improve health during the post-release period.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clatsop County Corrections

Warrenton, Oregon, 97146, United States

Location contact

Thomas Teague Jail Commander

CONTACT

[email protected]

5033258641

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be adults (age ≥18 years) currently incarcerated at Clatsop County Jail
  • Be enrolled in the jail's MOUD program at the time of recruitment
  • Plan to continue MOUD with Clatsop Behavioral Healthcare upon release
  • Speak English and be able to provide informed consent

Exclusion criteria

Exclusion criteria

  • Are unable to provide informed consent due to cognitive impairment or acute psychiatric instability
  • Are scheduled for transfer to a different facility or geographic location that prevents post-release participation

Treatment and study plan

Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention

Other

Participants receive gift card rewards for attending MOUD appointments and counseling appointments after release from incarceration.

Primary outcomes

  1. Number of patients receiving medication for opioid use disorder

    Time frame: 1, 2, and 3 months

    We will assess patient reported receipt of medication for opioid use disorder and also use chart review to determine whether patients are receiving medications and three different time points.

Secondary outcomes

  1. Number of contingency management sessions attended

    Time frame: 3 months

    Number of contingency management sessions attended per participant

  2. Total contingency management rewards earned

    Time frame: 3 months

    Total dollar amount of contingency management rewards earned by participant throughout the intervention

  3. Addiction Severity

    Time frame: Baseline and 3 months

    Participant reported addiction severity using the validated Brief Addiction Monitor, a 17-item, multidimensional progress monitoring tool designed to support the provision of measurement-based care to patients commencing and matriculating through treatment for substance use disorders (SUD). The BAM items assess: (1) Risk for relapse or worsening severity of SUD (Range 0-180 with higher scores indicating higher risk), (2) Protective behaviors that support recovery and resistance to relapse (Range 0-180 with higher score indicating higher protective factors), and (3) Use of alcohol and other substances (Range 0-90 with higher score indicating higher substance use).

  4. Recovery Capital

    Time frame: Baseline and 3 months

    Participant reported survey on recovery capital using the validated "Brief Assessment of Recovery Capital (BARC-10)" survey. Score range 10-60 with higher scores indicating higher recovery capital.

Study contacts

Contact information is provided by the study sponsor or research team.

Carol DeFrancesco Senior Research Associate

CONTACT

[email protected]

5033105036

Linda Peng, MD

CONTACT

[email protected]

5034941801

Sponsors and collaborators

Lead sponsor

Oregon Health and Science University

Other

Collaborators

  • Clatsop Behavioral Healthcare
  • Clatsop County Corrections
  • Oregon Health Authority

Registry information

Official study title

Enhancing Medication for Opioid Use Disorder Retention With Post-Release Contingency Management

Acronym: RISE-CM

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jan 7, 2026
Registry last updated
Jan 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.